Formulation and Characterization of Novel Ethanolic Carrier for Improves Penetration of Serratiopeptidase

Authors

  • Vijayan Venugopal Unit of Pharmaceutical Technology, Faculty of Pharmacy, AIMST University, Malaysia
  • Kalaimanai Jayaraja Kumar Unit of Pharmaceutical Technology, Faculty of Pharmacy, AIMST University, Malaysia
  • Selvadurai Muralidharan Unit of Pharmaceutical Technology, Faculty of Pharmacy, AIMST University, Malaysia
  • Subramani Parasuraman Unit of Pharmaceutical Technology, Faculty of Pharmacy, AIMST University, Malaysia

DOI:

https://doi.org/10.37591/rrjodfdp.v2i1.320

Abstract

The aim of present study was to develop ethanolic vesicles of proteolytic enzyme Serratiopeptidase (SRP) by solvent evaporation with high speed homogenization method and to evaluate the Serratiopeptidase ethosomes in treating the topical inflammation. The feasibility of SRP niosomes prepared by using lecithin and ethanol has been successfully demonstrated in this investigation. The entrapment efficiency was found to be influenced by the molar ratio of lecithin: ethanol concentration of SRP in ethosomes. The developed ethosomes were characterized for morphology, particle size, and in vitro release. SRP niosomes obtained were round in nanosized range. At lecithin: ethanol molar ratio 2.5:1 entrapment efficiency was maximum, that is, 75.37% ± 0.67, and showed consistent release pattern over 24 h.

 

Keywords: Ethosomes, Serratiopeptidase (SRP), lecithin, anti-inflammatory

Downloads

Published

2019-02-26

Issue

Vol. 2 No. 1 (2015)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.